pharmaphorum

SEPTEMBER 23, 2020

Sixfold Bioscience and Medicines Discovery Catapult awarded Innovate UK grant to pursue ground-breaking project. Programmable Oligonucleotide Delivery System (PODS), developed by Sixfold Bioscience, is a versatile system which delivers short interfering RNA (siRNA) gene silencing cargo to specific cancer cells.

Drug Delivery Systems 141

Drug Delivery Systems Gene Silencing Drug Delivery Medicine 141

Drug Discovery World

FEBRUARY 5, 2024

Through early diagnosis and precision medicine, we can improve quality of life and enable more people with cancer to survive. Dr Gen Li, Founder and President, Phesi “In 2024, we can expect immunotherapy trials to become a driving force for change in clinical development.

Research 116

Research Drug Delivery Systems Gene Sequencing Trials 116

XTalks

MAY 23, 2024

Innovations in Skin Cancer Treatment: Precision Medicine and Immunotherapy Treatment options for skin cancer have considerably evolved with a growing emphasis on precision medicine and immunotherapy. Precision medicine allows more effective and personalized treatment plans, which minimizes side effects and improves patient outcomes.

Life Science 72

Life Science Dermatology Drug Delivery Systems Medicine 72